0000000000669239

AUTHOR

Karuza-maria Alves-pereira

showing 2 related works from this author

Preemptive analgesia-related gene and protein expression in third molar surgeries under non steroidal anti-inflammatory drug protocols : A PROSPERO-r…

2018

Background This study aimed to review translational studies focusing on third molar removal surgeries through a systematic analytical approach. Material and Methods A PROSPERO-registered systematic review (CRD42017060455) was conducted following the PRISMA statement to summarize current knowledge on gene expression in third molar surgeries. A search was performed in PubMed’s Medline and Scopus databases, without date or language restrictions, using the logical expression {[(Third molar) OR (preemptive) OR (cyclooxygenase inhibitors) OR (acute inflammation) AND (gene expression)]}. Results All studies included in the analysis evaluated gene expression in a third molar extraction model, using…

DrugGene isoformMolarmedia_common.quotation_subjectMEDLINEGene ExpressionReviewBioinformatics03 medical and health sciences0302 clinical medicineText miningGene expressionBiopsyMedicineHumans030212 general & internal medicineGeneral Dentistrymedia_commonmedicine.diagnostic_testbusiness.industryAnti-Inflammatory Agents Non-Steroidal030206 dentistry:CIENCIAS MÉDICAS [UNESCO]TransudateOtorhinolaryngologyProstaglandin-Endoperoxide SynthasesProtein BiosynthesisUNESCO::CIENCIAS MÉDICASSurgeryMolar ThirdAnalgesiaOral Surgerybusiness
researchProduct

RT-qPCR study of COX-1 and -2 genes in oral surgical model comparing single-dose preemptive ibuprofen and etoricoxib: A randomized clinical trialy

2019

Background This study aimed to evaluate the gene expression of cyclooxygenases (COXs) in an oral model of preemptive analgesia. Material and Methods Gingival tissue was collected during extraction of lower third molars from a randomized, triple-blind, split-mouth and placebo-controlled study. The eligible patients were randomly sorted to receive a single dose either of ibuprofen 400mg, or etoricoxib 120 mg or a placebo, one hour prior to surgery. The temporal course of RNAm was evaluated for COX-1 and -2 by means of a quantitative polymerase chain reaction in real time (RT-qPCR) at time zero and 30 minutes after the surgical procedure began, and it was correlated with clinical parameters (p…

Molarmedicine.medical_specialtyTime zerobusiness.industryResearchmedicine.medical_treatment030206 dentistry:CIENCIAS MÉDICAS [UNESCO]PlaceboIbuprofenGastroenterology03 medical and health sciences0302 clinical medicineReal-time polymerase chain reactionDental extraction030220 oncology & carcinogenesisInternal medicineUNESCO::CIENCIAS MÉDICASmedicineOral SurgerybusinessGeneral DentistryEtoricoxibTissue inflammationmedicine.drugJournal of Clinical and Experimental Dentistry
researchProduct